We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Vesper Homes are a hybrid estate agents leading a rental revolution and aiming to save landlords and vendors an average of 50%. They are an expanding residential services company offering clients significantly lower fees and are looking to deploy a leading edge technology platform to improve services for both landlords and tenants. 
days to go: Expired investment: £121,371
Warehouse home cater to urban living by specialising in the industrial home styling niche. They publish high end print and digital magazines bi-annually which feature styling tips and also real homes, and also have an online shop with carefully sourced designs for the ever growing industrial style home. 
days to go: Expired investment: £42,330
An online marketplace offering people to invest in global properties. Wealth Migrate allows investors to diversify their portfolios through a safe and simple platform that uses SMART Investing technology. Investors from 55 countries have performed over 2100 transactions, with each transaction averaging £29.4k and receiving returns ranging from 7% to 12%. In 2017, over £1.1m of revenue was generated from 846 transactions. Wealth Migrate's main sources of income are derived from equity raising fees, investment management fees and exit fees on the demand side. The company intends to reduce its minimum investment amount to attract more customers to the marketplace.
days to go: Expired investment: £1,980,450
The Vikare Tuscan Property Fund owns a development site near Florence known locally as Mille Pini, and has full planning consent to build more than 80 apartments and a spacious clubhouse.Mille Pini is an exceptional ... Read more
days to go: Expired investment: £110,000
Vikare Tuscan Property owns a development site near Florence known locally as Mille Pini, and has full planning consent to build more than 80 apartments and a spacious clubhouse.
days to go: Expired investment: £200,000
Handsome are one of the leading brands of back care stocked in over 1000 stores such as boots and CVS Pharmacy. They stock a comprehensive range of award winning products for pain relief and posture management and aim to become the leading consumer brand in back care through their brand BAC< BackPainHelp.
days to go: Expired investment: £514,530
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go: Expired investment: £357,179
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go: Expired investment: £62,770
FreeHand is a robotic surgical camera controller that aims to make surgeries precise and safer. The company cites data arguing that over 15 million keyhole surgeries are performed annually in which an additional clinician is mostly required to manually hold the camera the surgeon uses to see the operating field. The company asserts that this is not the most optimal way. FreeHand's robotic camera controller aims to solve this issue by providing steady images and precise control, saving time, and improving outcomes. The company has regulatory clearance for sale in the EU, US, and Japan. FreeHand points out that surgical robotics is one of the fastest-growing segments in Medical Technology, projected to reach $91.5 billion by 2025. It aims to become a contender in this segment. FreeHand claims that surgeons have successfully used its robotic controller in more than 15,000 procedures. The company will use the investment to expand the distributor base in Europe, Asia and Latin America, targeting over 12 million procedures annually.
days to go: Expired investment: £1,003,350
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings. 
days to go: Expired investment: £1,126,464
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph